Reservoir Design and Dose Availability with Long-term Metered Dose Inhaler Corticosteroid Use

Journal of Aerosol Medicine: Deposition, Clearance, and Effects in the Lung

Volumn 11, Issue 1, 1998, Pages 15-26

  Rau, Joseph L ^a   Zhu, Yanzhi ^a  

^a GEORGIA STATE UNIVERSITY   (United States)

Author keywords

Corticosteroid; Holding chamber; Long term use; Metered dose inhaler; Reservoir

Indexed keywords

BECLOMETASONE DIPROPIONATE; CORTICOSTEROID;

AEROSOL; ARTICLE; CLEANING; DOSE CALCULATION; LUNG MODEL; METERED DOSE INHALER;

EID: 0031906854     PISSN: 08942684     EISSN: None     Source Type: Journal    
DOI: 10.1089/jam.1998.11.15     Document Type: Article

References (29)

1. Epstein, S.W., C.P.R. Manning, M.J. Ashley, and P.N. Corey. 1979. Survey of the clinical use of pressurized aerosol inhalers. Can. Med. Assoc. J. 120:813-816.
2. Gayrard, P., and J. Orehek. 1980. Inadequate use of pressurized aerosols by asthmatic patients. Respiration 40:47-52.
3. Horsley, M.G., and G.R. Bailie. 1988. Risk factors for inadequate use of pressurized aerosol inhalers. J. Clin. Pharm. Ther. 12:139-143.
4. Crompton, G. 1982. Problems patients have using pressurized aerosol inhalers. Eur. Respir. J. 63(Suppl 119): 101-104.
5. Coady, T.J., C.J. Stewart, and H.J. Davies. 1976. Synchronization of bronchodilator release. Practitioner 217:273-275.
6. Orehek, J., P. Gayrard, C.H. Grimaud, and J. Charpin. 1976. Patient error in use of bronchodilator metered aerosols. B.M.J. 1:76.
7. Saunders, K.B. 1965. Misuse of inhaled bronchodilator agents. B.M.J. 1:1037-1038.
8. Paterson, I.C., and G.K. Crompton. 1976. Use of pressurized aerosols by asthmatic patients. B.M.J. 1:76-77.
9. Newman, S., D. Pavia, F. Moren, N.F. Sheahan, and S.W. Clarke. 1981. Deposition of pressurized aerosols in the human respiratory tract. Thorax 36:52-55.
10. Toogood, J.H., B. Jennings, R.W. Greenway, and L. Chuang. 1980. Candidiasis and dysphonia complicating beclomethasone treatments of asthma. J. Allergy Clin. Immunol. 65:145-153.
11. Dolovich, M., R. Ruffin, D. Corr, and M.T. Newhouse. 1983. Clinical evaluation of a simple demand inhalation MDI aerosol delivery device. Chest 84:36-41.
12. Ranee, R.W. 1974. Studies of the factors controlling the action of hair sprays-III. The influence of particle velocity and diameter on the capture of particles by arrays of hair fibres. J. Soc. Cosmet. Chem. 25:545-561.
13. Sackner, M.A., and C.S. Kim. 1985. Auxiliary MDI aerosol delivery systems. Chest 88(suppl):161S-170S.
14. Kim, C.S., D. Trujillo, and M.A. Sackner. 1985. Size aspects of metered-dose inhaler aerosols. Am. Rev. Respir. Dis. 132:137-142.
15. Kim, C.S., M.A. Eldridge, and M.A. Sackner. 1987. Oropharyngeal deposition and delivery aspects of metered-dose inhaler aerosols. Am. Rev. Respir. Dis. 135:157-164.
16. Tobin, M.J., G. Jenouri, I. Danta, C. Kim, H. Watson, and M.A. Sackner. 1982. Response to bronchodilator drug administration by a new reservoir aerosol delivery system and a review of other auxiliary delivery systems. Am. Rev. Respir. Dis. 126:670-675.
17. Newman, S.P., F. Moren, D. Pavia, F. Little, and S.W. Clarke. 1981. Deposition of pressurized suspension aerosols inhaled through extension devices. Am. Rev. Respir. Dis. 124:317-320.
18. Newman, S.P., A.B. Millar, T.R. Lennard-Jones, F. Moren, and S.W. Clarke. 1984. Improvement of pressurized aerosol deposition with Nebuhaler spacer device. Thorax 39:935-941.
19. Toogood, J., B. Jennings, J. Baskerville, N. Lefcoe, and M. Newhouse. 1981. Assessment of a device for reducing oropharyngeal complications during beclomethasone treatment of asthma [abstract]. Am. Rev. Respir. Dis. 123(suppl):113.
20. Toogood, J.H., J. Baskerville, B. Jennings, N.M. Lefcoe, and S.A. Johansson. 1984. Use of spacers to facilitate inhaled corticosteroid treatment of asthma. Am. Rev. Respir. Dis. 129:723-729.
21. Toogood, J.H., B. Jennings, J. Baskerville, and S.A. Johanssen. 1982. Clinical use of spacer systems for corticosteroid inhalation therapy: A preliminary analysis. Eur. J. Respir. Dis. 63(Suppl 122): 100-107.
22. Barnes, P.J. 1995. Inhaled glucocorticoids for asthma. N. Engl. J. Med. 332:868-875.
23. National Asthma Education and Prevention Program. 1997. Expert Panel Report II. Guidelines for the Diagnosis and Management of Asthma. National Institutes of Health, Bethesda, MD.
24. Rau, J.L., R.J. Harwood, J.L. Groff. 1992. Evaluation of a reservoir device for metered-dose bronchodilator delivery to intubated adults. An in vitro study. Chest 102:924-930.
25. Rau, J.L., Jr., and R.J. Harwood. 1992. Comparison of nebulizer delivery methods through a neonatal endotracheal tube: A bench study. Respir. Care 37:1233-1240.
26. Kirk, R.E. 1968. Experimental Design: Procedures for the Behavioral Sciences, Brooks/Cole Publishing, Belmont, CA, 268-270.
27. Ahrens, R., C. Lux, T. Bahl, and S. Han. 1995. Choosing the metered-dose inhaler spacer or holding chamber that matches the patient's need: Evidence that the specific drug being delivered is an important consideration. J. Allergy Clin. Immunol. 96:288-294.
28. Wildhaber, J.H., S.G. Devadason, M.J. Hayden, R. James, A.P. Dufty, R.A. Fox, Q.A. Summers, and P.N. LeSouef. 1996. Electrostatic charge on a plastic spacer device influences the delivery of salbutamol. Eur. Respir. J. 9:1943-1946.
29. O'Callaghan, C., J. Lynch, M. Cant, and C. Robertson. 1993. Improvement in sodium cromoglycate delivery from a spacer device by use of an antistatic lining, immediate inhalation, and avoiding multiple actuations of drug. Thorax 48:603-606.